195 related articles for article (PubMed ID: 35290637)
21. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
22. Non-redundancy of cytidine deaminases in class switch recombination.
Fugmann SD; Rush JS; Schatz DG
Eur J Immunol; 2004 Mar; 34(3):844-849. PubMed ID: 14991614
[TBL] [Abstract][Full Text] [Related]
23. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
Nabel CS; Jia H; Ye Y; Shen L; Goldschmidt HL; Stivers JT; Zhang Y; Kohli RM
Nat Chem Biol; 2012 Sep; 8(9):751-8. PubMed ID: 22772155
[TBL] [Abstract][Full Text] [Related]
24. Reward versus risk: DNA cytidine deaminases triggering immunity and disease.
Pham P; Bransteitter R; Goodman MF
Biochemistry; 2005 Mar; 44(8):2703-15. PubMed ID: 15723516
[TBL] [Abstract][Full Text] [Related]
25. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of base editors with anti-deaminases derived from viruses.
Liu Z; Chen S; Lai L; Li Z
Nat Commun; 2022 Feb; 13(1):597. PubMed ID: 35105899
[TBL] [Abstract][Full Text] [Related]
27. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
[TBL] [Abstract][Full Text] [Related]
28. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
Knisbacher BA; Gerber D; Levanon EY
Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
[TBL] [Abstract][Full Text] [Related]
29. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
30. New Insights Into the Lineage-Specific Expansion and Functional Diversification of Lamprey AID/APOBEC Family.
Chen Y; Luo L; Deng L; Tian X; Chen S; Xu A; Yuan S
Front Immunol; 2022; 13():822616. PubMed ID: 35359986
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming.
Morgan HD; Dean W; Coker HA; Reik W; Petersen-Mahrt SK
J Biol Chem; 2004 Dec; 279(50):52353-60. PubMed ID: 15448152
[TBL] [Abstract][Full Text] [Related]
32. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
33. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
Chen J; MacCarthy T
PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
[TBL] [Abstract][Full Text] [Related]
34. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
Anant S; Yu H; Davidson NO
Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
[TBL] [Abstract][Full Text] [Related]
35. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
[TBL] [Abstract][Full Text] [Related]
36. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
[TBL] [Abstract][Full Text] [Related]
37. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
38. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
39. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
Steele EJ
DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
[TBL] [Abstract][Full Text] [Related]
40. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]